158 related articles for article (PubMed ID: 16859609)
21. [Acute pleuropericarditis in a patient with Crohn's disease controlled with chronic therapy with mesalazine].
Merino Rivas JL; Arambarri Segura M; Quereda Rodríguez-Navarro C; Dronda Núñez F
Rev Clin Esp; 2002 Feb; 202(2):122-3. PubMed ID: 11996772
[No Abstract] [Full Text] [Related]
22. [A case of Crohn's disease that shows the improvement of the gastric disorder by the administration of mesalazine powder].
Nagamata H; Torii A; Izumi M; Anami M; Yamashita N; Inadama E; Toda G
Nihon Shokakibyo Gakkai Zasshi; 2000 Oct; 97(10):1261-6. PubMed ID: 11075590
[No Abstract] [Full Text] [Related]
23. [Crohn's disease, primary sclerosing cholangitis and antiphospholipid syndrome: an uncommon association].
Romdhane H; Karoui S; Serghini M; Boubaker J; Filali A
Tunis Med; 2009 May; 87(5):349-51. PubMed ID: 19927768
[TBL] [Abstract][Full Text] [Related]
24. Acute renal failure in a 53-year-old woman with Crohn's disease treated with 5-aminosalicylic acid.
Haas M; Shetye KR
Am J Kidney Dis; 2001 Jul; 38(1):205-9. PubMed ID: 11431204
[No Abstract] [Full Text] [Related]
25. Fever induced by mesalazine.
Pizarro Carbajo I; Gutiérrez Macías A; Cea Gómez M; Lombide Aguirre I
Gastroenterol Hepatol; 2018 Apr; 41(4):261-262. PubMed ID: 28431755
[No Abstract] [Full Text] [Related]
26. Mesalazine as a maintenance treatment in Crohn's disease.
Sutherland LR; Steinhart AH
Gut; 1998 Jan; 42(1):143-4. PubMed ID: 9505902
[No Abstract] [Full Text] [Related]
27. A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.
Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E
N Engl J Med; 1998 Aug; 339(6):370-4. PubMed ID: 9691103
[TBL] [Abstract][Full Text] [Related]
28. [Diagnostic difficulties in Churg-Strauss syndrome].
Zielonka TM; Dabrowski A; Droszcz W
Pneumonol Alergol Pol; 1991; 59(5-6):224-8. PubMed ID: 1688223
[TBL] [Abstract][Full Text] [Related]
29. Nephrotic syndrome from 5-ASA for ulcerative colitis? Complicated by carcinoma of the colon and sclerosing cholangitis.
Fornaciari G; Maccari S; Borgatti PP; Rustichelli R; Amelio N; Lattuada I; Plancher AC
J Clin Gastroenterol; 1997 Jan; 24(1):37-9. PubMed ID: 9013349
[TBL] [Abstract][Full Text] [Related]
30. Mesalazine-induced Pleuropericarditis in a Patient with Crohn's Disease.
Kiyomatsu H; Kawai K; Tanaka T; Tanaka J; Kiyomatsu T; Nozawa H; Kanazawa T; Kazama S; Ishihara S; Yamaguchi H; Sunami E; Watanabe T
Intern Med; 2015; 54(13):1605-8. PubMed ID: 26134190
[TBL] [Abstract][Full Text] [Related]
31. Investigation of a High-Dose pH-Dependent-Release Mesalazine on the Induction of Remission in Active Crohn's Disease.
Suzuki Y; Iida M; Ito H; Tachikawa N; Hibi T
Drugs R D; 2016 Mar; 16(1):35-43. PubMed ID: 26883035
[TBL] [Abstract][Full Text] [Related]
32. Adverse reaction in a patient with aspirin-induced asthma treated with zafirlukast.
Reyes-Balaguer J; Hernández de Rojas D
J Investig Allergol Clin Immunol; 2006; 16(1):69-70. PubMed ID: 16599252
[TBL] [Abstract][Full Text] [Related]
33. Maintaining remissions across the lifespan: a roundtable discussion with Crohn's disease experts.
Lichtenstein GR; Cuffari C; Kane SV; Hanauer S; Present DH
Inflamm Bowel Dis; 2004 Jul; 10 Suppl 2():S11-21. PubMed ID: 15475769
[No Abstract] [Full Text] [Related]
34. Polymyositis, alopecia universalis, and primary sclerosing cholangitis in a patient with Crohn's disease.
Seibold F; Klein R; Jakob F
J Clin Gastroenterol; 1996 Sep; 23(2):121-4. PubMed ID: 8877639
[TBL] [Abstract][Full Text] [Related]
35. [Tubulo-interstitial nephritis in inflammatory bowel disease: extra-intestinal manifestation or drug toxicity?].
Heidt J; Ooms EC; van der Werf SD; Groeneveld JH
Ned Tijdschr Geneeskd; 2010; 154():A1647. PubMed ID: 20699041
[TBL] [Abstract][Full Text] [Related]
36. Little benefit from mesalazine taken prophylactically after surgery for Crohn's disease.
Rutgeerts P
Gut; 2001 Apr; 48(4):452-3. PubMed ID: 11247886
[No Abstract] [Full Text] [Related]
37. [Allergic vasculitis and granulomatosis (Churg-Strauss syndrome)].
Zielonka TM; Droszcz W
Pneumonol Alergol Pol; 1991; 59(5-6):237-41. PubMed ID: 1843927
[No Abstract] [Full Text] [Related]
38. Mesalazine-induced lung fibrosis.
Alskaf E; Aljoudeh A; Edenborough F
BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23576654
[TBL] [Abstract][Full Text] [Related]
39. Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial.
Prantera C; Cottone M; Pallone F; Annese V; Franzè A; Cerutti R; Bianchi Porro G
Gastroenterology; 1999 Mar; 116(3):521-6. PubMed ID: 10029609
[TBL] [Abstract][Full Text] [Related]
40. Myocarditis by mesalazine with cardiac magnetic resonance imaging.
García-Ferrer L; Estornell J; Palanca V
Eur Heart J; 2009 Apr; 30(8):1015. PubMed ID: 19168869
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
